Kalyanasundaram A, Berger PB. Routine platelet testing should not be performed on all patients undergoing percutaneous coronary intervention[J]. Circ Cardiovasc Interv, 2010, 3(3):284-287.
[2]
Carter AM. Inflammation, thrombosis and acute coronary syndromes[J]. Diab Vasc Dis Res, 2005, 2(3): 113-121.
[3]
Kim HA, Seo KH, Kang YR. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression[J]. Cell Physiol Biochem, 2011,27(1):55-62.
[4]
Koda M, Banno Y, Naganawa T. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets[J]. Platelets, 2005, 16(18):482-491.
[5]
Kidson-Gerber G, Weaver J, Gemmell R, et al. Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease[J]. Heart Lung Circ, 2010, 19(4):234-242.
Zimmerman GA, Mcintyre TM, Prescott SM, et a1.The platelet activating factor signaling system and its regulators in syndromes of inflammation and thrombosis[J].Crit Care Med, 2002, 30(5Supp1):294-301.
[8]
Louis NA, Hamilton KE, Colsan SP. Lipid mediator networks and leukocyte transmigration[J]. Prostaglandins Leukot Essent Fatty Acids, 2005, 73(3-4):197-202.
